Dianthus Therapeutics to Participate in Two Upcoming Investor Events

Rhea-AI Summary

Dianthus Therapeutics, a clinical-stage biotech company focused on developing antibody complement therapeutics for autoimmune diseases, has announced its participation in two major investor events.

The company will be featured at:

• Baird Biotech Discovery Series - CEO Marino Garcia will join a fireside chat on May 6, 2025, at 1:30 p.m. EDT
• Bank of America 2025 Health Care Conference - Garcia will present a corporate overview on May 14, 2025, at 5:35 p.m. EDT and conduct one-on-one investor meetings

Both presentations will be accessible via webcast through the "News and Events" section of Dianthus Therapeutics' investor website.

Positive

• CEO's participation in two major healthcare investment conferences indicates strong institutional interest
• Company maintains active investor relations and market visibility through high-profile events

Negative

• None.

News Market Reaction

+1.40%

1 alert

+1.40% News Effect

On the day this news was published, DNTH gained 1.40%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK and WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation at two upcoming investor events.

• Baird Biotech Discovery Series - Marino Garcia, Chief Executive Officer, will participate in a fireside chat webcast on Tuesday, May 6 at 1:30 p.m. EDT.
  
  
• Bank of America 2025 Health Care Conference – Marino Garcia, Chief Executive Officer, will present a corporate overview on Wednesday, May 14 at 5:35 p.m. EDT / 2:35 p.m. PDT and will host one-on-one meetings with investors.
  

Webcasts of these presentations may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

About Dianthus Therapeutics
Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

To learn more, please visit www.dianthustx.com and follow us on LinkedIn. 

Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com

FAQ

When is Dianthus Therapeutics (DNTH) presenting at the Bank of America 2025 Health Care Conference?

Dianthus Therapeutics (DNTH) will present at the Bank of America 2025 Health Care Conference on Wednesday, May 14 at 5:35 p.m. EDT / 2:35 p.m. PDT.

Where can investors watch Dianthus Therapeutics (DNTH) investor presentations in May 2025?

Investors can access webcasts of both presentations under the 'News and Events' section in the Investors portion of the Dianthus Therapeutics website.

What upcoming investor events is Dianthus Therapeutics (DNTH) attending in May 2025?

Dianthus Therapeutics is participating in two events: the Baird Biotech Discovery Series on May 6 and the Bank of America 2025 Health Care Conference on May 14.

What time is the Dianthus Therapeutics (DNTH) fireside chat at the Baird Biotech Discovery Series?

The fireside chat webcast at the Baird Biotech Discovery Series is scheduled for Tuesday, May 6 at 1:30 p.m. EDT.

Will Dianthus Therapeutics (DNTH) offer one-on-one investor meetings at the Bank of America conference?

Yes, Dianthus Therapeutics will host one-on-one meetings with investors at the Bank of America 2025 Health Care Conference.